Table 2. Serological and survival results of naïve E. fuscus inoculated with a homologous or heterologous rabies virus variant.
| Virus variant | Group | dose | Bat no | DFA | Incubation time in days pi | + Oral swab in days pi | Infecting Variant | Rabies virus titer VNA (IU/ml) days post primary inoculation | ||||||||
| 7 | 21 | 49 | * | 245 | 259 | 287 | 315 | 364 | ||||||||
| EfV1 | 1 | 103 | ||||||||||||||
| 1 | + | 17 † | N | EfV2 | <0.125a | <0.125 | <0.125 | <0.125 | <0.125b | |||||||
| 2 | + | 16 | N | EfV2 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125b | |||||||
| 3 | + | 64 | N | EfV1 | <0.125 | <0.125 | <0.125b | |||||||||
| 4 | + | 26 | 19,23 | EfV1 | <0.125 | <0.125 | <0.125b | |||||||||
| 5 | + | 18 | N | EfV2 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125b | |||||||
| EfV2 | 2 | 103 | ||||||||||||||
| 6 | + | 16 | 16 | EfV2 | <0.125b | |||||||||||
| 7 | + | 69 | N | EfV2 | <0.125 | <0.125 | <0.125b | |||||||||
| 8 | + | 19 | N | EfV2 | <0.125 | <0.125b | ||||||||||
| 9 | + | 22 | N | EfV2 | <0.125 | <0.125b | ||||||||||
| 10 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | ||||||||
| LnV1 | 3 | 103 | ||||||||||||||
| 11 | 56 | N | EfV2 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125b | ||||||||
| 12 | 26 | N | EfV2 | <0.125 | 0.125c | <0.125 | <0.125 | <0.125b | ||||||||
| 13 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | <0.125 | ||||||||
| 14 | 20 | N | EfV2 | <0.125 | <0.125 | <0.125 | <0.125 | 0.5b | ||||||||
| 15 | + | 25 | 23 | LnV1 | <0.125 | <0.125 | ||||||||||
Time point of 238 day challenge.
Incubation times in bold are days post 238 challenge.
N = Negative.
<0.125 indicates the results are below the limit of detection for our test.
denotes terminal bleed.
Demonstrated some neutralizing activity.